Journal of Antimicrobial Chemotherapy (2000) 46, 199-203
© 2000 The British Society for Antimicrobial Chemotherapy
Efflux-mediated resistance to fluconazole could be modulated by sterol homeostasis in Saccharomyces cerevisiae
Department of Medical Specialties, Section of Infectious Diseases, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Box 47, Houston, TX 77030, USA
Saccharomyces cerevisiae has long been used as a model organism in the study of the ergosterol pathway and its inhibitors. The Pdr5 protein (Pdr5p), an ATP binding cassette transporter, plays an important role in active efflux of azole antifungals and therefore in azole sensitivity and resistance in S. cerevisiae. We have identified the Fluconazole Dominant Resistance-1 (FDR-1) mutant, which has a single dominant mutation conferring high-level resistance to fluconazole. FDR-1 has been found to be an activated allele of the Pleiotropic Drug Resistance-1 (PDR-1) gene (termed PDR1-100) and to upregulate PDR5 transcription. Resistance of PDR1-100 to fluconazole decreased in the background of mutations known to affect sterol homeostasis. Hence, the resistance to fluconazole of PDR1-100 was paradoxically decreased in an erg3 PDR1-100 double mutant. The erg3 mutants are resistant to azoles and accumulate 14-methyl-fecosterol instead of ergosterol in the presence of azoles. These results reinforce the emerging evidence in both S. cerevisiae and Candida albicans that sterols could serve as substrates for Pdr5p for transport across membranes.
* Corresponding author. Tel: +1-713-792-0826; Fax: +1-713-794-4351; E-mail: dkontoyi{at}notes.mdacc.tmc.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. B. Anderson, N. Ricker, and C. Sirjusingh Antagonism between Two Mechanisms of Antifungal Drug Resistance. Eukaryot. Cell, August 1, 2006; 5(8): 1243 - 1251. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wolfger, Y. M. Mamnun, and K. Kuchler The Yeast Pdr15p ATP-binding Cassette (ABC) Protein Is a General Stress Response Factor Implicated in Cellular Detoxification J. Biol. Chem., March 19, 2004; 279(12): 11593 - 11599. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Mukherjee, J. Chandra, D. M. Kuhn, and M. A. Ghannoum Mechanism of Fluconazole Resistance in Candida albicans Biofilms: Phase-Specific Role of Efflux Pumps and Membrane Sterols Infect. Immun., August 1, 2003; 71(8): 4333 - 4340. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gauthier, S. Weber, A.-M. Alarco, O. Alqawi, R. Daoud, E. Georges, and M. Raymond Functional Similarities and Differences between Candida albicans Cdr1p and Cdr2p Transporters Antimicrob. Agents Chemother., May 1, 2003; 47(5): 1543 - 1554. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mukhopadhyay, A. Kohli, and R. Prasad Drug Susceptibilities of Yeast Cells Are Affected by Membrane Lipid Composition Antimicrob. Agents Chemother., December 1, 2002; 46(12): 3695 - 3705. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Le Crom, F. Devaux, C. Jacq, and P. Marc yMGV: helping biologists with yeast microarray data mining Nucleic Acids Res., January 1, 2002; 30(1): 76 - 79. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nakamura, M. Niimi, K. Niimi, A. R. Holmes, J. E. Yates, A. Decottignies, B. C. Monk, A. Goffeau, and R. D. Cannon Functional Expression of Candida albicans Drug Efflux Pump Cdr1p in a Saccharomyces cerevisiae Strain Deficient in Membrane Transporters Antimicrob. Agents Chemother., December 1, 2001; 45(12): 3366 - 3374. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Kontoyiannis Modulation of fluconazole sensitivity by the interaction of mitochondria and Erg3p in Saccharomyces cerevisiae J. Antimicrob. Chemother., August 1, 2000; 46(2): 191 - 197. [Abstract] [Full Text] [PDF] |
||||





